| 79.82 Delayed Data As of May 20 |  +0.36 / +0.45%Today’s Change | 75.62 Today|||52-Week Range 107.25 | -13.42% Year-to-Date |
| Previous close | 79.46 |
| Today’s open | 79.02 |
| Day’s range | 78.91 - 80.39 |
| Volume | 4,395,510 |
| Average volume (3 months) | 6,299,600 |
| Market cap | $117.5B |
| Earnings growth (last year) | +10.88% |
| Earnings growth (this year) | +11.04% |
| Earnings growth (next 5 years) | +5.67% |
| Revenue growth (last year) | +16.08% |
| P/E ratio | 22.4 |
| Price/Sales | 4.35 |
| Price/Book | -- |
| Today’s change | Today’s % change | |
|---|---|---|
| LLYEli Lilly and Co | +0.22 | +0.19% |
| SNYSanofi | -0.47 | -1.12% |
| ABTAbbott Laboratories | -0.20 | -0.26% |
| GSKGlaxoSmithKline | -0.07 | -0.18% |
| Next reporting date | July 29, 2019 |
| EPS forecast (this quarter) | $2.20 |
| Annual revenue (last year) | $32.8B |
| Annual profit (last year) | $5.7B |
| Net profit margin | 17.27% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
Chairman & Chief Executive Officer Richard A. Gonzalez |
Vice Chairman & President Michael E. Severino |
Corporate headquarters North Chicago, Illinois |
